In recent years, Canadian and other international thyroid guidelines have enacted local policies that restrict thyroid therapy and testing, often citing the American Thyroid Association (ATA) & American Association of Clinical Endocrinologists' (AACE) guidelines in 2012. What most "guideline policers" fail to notice is that the 2012 ATA-AACE's guidelines begin with a disclaimer against their … Continue reading 2012 ATA thyroid guidelines ask for clinicians’ independent judgment
Category: Endocrinologists / CSEM
The loss of thyroid clinical knowledge from Werner & Ingbar’s The Thyroid
Decades ago, a lot more doctors knew how thyroid hormone levels influenced all organs and tissues’ health. It wasn’t all about the influence of thyroid hormones on the TSH. It was more about the influence of truly adequate thyroid hormone levels on real health outcomes. A lot more doctors learned and understood that if thyroid … Continue reading The loss of thyroid clinical knowledge from Werner & Ingbar’s The Thyroid
2014 ATA therapy guidelines: 5. Research
This post continues my series of paraphrases of Jonklaas et al's 2014 guidelines that I left unfinished weeks ago. Posts in this series: 2014 ATA Thyroid therapy guidelines: 1. Levothyroxine 2014 ATA Thyroid therapy guidelines: 2. Ethics2014 ATA Therapy guidelines: 3. Desiccated thyroid2014 ATA Therapy guidelines: 4. Using Synthetic T32014 ATA therapy guidelines: 5. Research … Continue reading 2014 ATA therapy guidelines: 5. Research
Dr. Ron Matsusaki’s license to treat thyroid suspended April 17, 2019
One of Canada's best thyroid doctors, Dr. Ron Matsusaki in Nova Scotia, has had his license to prescribe and treat thyroid suspended. His thyroid clinic in Digby has been under review for the past month, and the decision was announced on the clinic's Facebook group April 17, 2019.(1) Let's do everything we can to speak … Continue reading Dr. Ron Matsusaki’s license to treat thyroid suspended April 17, 2019
CSEM attempts to dialogue with thyroid patients, April 8, 2019
In my previous post, I discussed the statement of the Canadian Society of Endocrinology and Metabolism (CSEM) response to thyroid patients' concerns, dated April 8th, 2019. There, I showed that the minor edit of adding a clause about central hypothyroidism is not really an update to the guidelines, which already acknowledged this exception. The document … Continue reading CSEM attempts to dialogue with thyroid patients, April 8, 2019